Legal Representation
Attorney
Jeffrey B. Oster
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 9, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 6, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 11, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 11, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 31, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 30, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 19, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 18, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Therapeutic pharmaceutical for the treatment of cancer, neurodegerative diseases inflammatory diseases, and other conditions which can be treated, relieved or prevented by antibodies that bind to activate or block a target antigen
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005